Is Fiserv (FISV) Poised to Rebuild Investor Confidence?

1 hour ago 1

Soumya Eswaran

Thu, March 5, 2026 astatine 7:33 AM CST 4 min read

Patient Capital Management, a worth investing firm, released its “Patient Opportunity Equity Strategy” fourth-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. In Q4 2025, Patient Opportunity Equity Strategy returned 5.99% nett of fees, compared to its unmanaged benchmark, the S&P 500 Index, which returned 2.65%. Through a three-factor show attribution model, the portfolio's outperformance was attributed to allocation, selection, and enactment effects. The marketplace ended a beardown twelvemonth with 17.9% returns, marking the seventh-best three-year play successful marketplace history. 2025 was a twelvemonth of AI, extending the benefits to hardware, energy, and constituent suppliers crossed the ecosystem. Seven stocks accounted for implicit fractional of the S&P 500’s returns, posing difficulties for progressive managers. Nevertheless, the strategy performed well, outperforming the S&P 500 for the 3rd consecutive twelvemonth with a instrumentality of 26.1%. Please reappraisal the Strategy’s apical 5 holdings to summation insights into their cardinal selections for 2025.

In its fourth-quarter 2025 capitalist letter, Patient Opportunity Equity Strategy stocks similar Fiserv, Inc. (NASDAQ:FISV). Fiserv, Inc. (NASDAQ:FISV) is an American fiscal exertion institution that provides exertion services and solutions. On March 04, 2026, Fiserv, Inc. (NASDAQ:FISV) banal closed astatine $62.60 per share. One-month instrumentality of Fiserv, Inc. (NASDAQ:FISV) was 7.12%, and its shares mislaid 73.40% implicit the past 12 months. Fiserv, Inc. (NASDAQ:FISV) has a marketplace capitalization of $71.54 billion.

Patient Opportunity Equity Strategy stated the pursuing regarding Fiserv, Inc. (NASDAQ:FISV) successful its 4th fourth 2025 capitalist letter:

"We built up a tiny presumption successful Fiserv, Inc. (NASDAQ:FISV), a sanction we cognize well, arsenic the institution traded down from its highest successful aboriginal March arsenic topline maturation disappointed. Fiserv is simply a sanction we antecedently owned and exited successfully successful precocious 2024. The institution is simply a person successful the payments space, and our archetypal concern was based connected the content that the marketplace was underappreciating its quality to proceed gaining stock portion improving margins. We deliberation today’s pullback has created a akin setup. Following the assignment of a caller CEO, a implicit reset of guidance, and a renewed absorption connected a client-first culture, we judge the institution is good positioned to rebuild capitalist assurance and instrumentality to delivering double-digit EPS maturation by 2027.

Read Entire Article